concise.news
OriginalSourceAP NewsUnited StatesLeanCenterCredibilityPublished20:27 UTCRatings: AllSides, MBFCSourceAP NewsUnited StatesLeanCenterCredibilityPublished20:27 UTCRatings: AllSides, MBFC

“FDA adds rare vision-loss warning to popular GLP-1 drugs”

FDA adds a rare vision-loss warning to popular GLP-1 drugs.

Read at AP News

Other reports

How it got here

  1. AP News publishes the article.

  2. concise.news reads it.

  3. Grouped with 8 other reports as story 9.

  4. The Brief ranks it 9th.

    9
    Health

    FDA requires GLP-1 drugs to warn about potential vision loss risk.

    NAION is an eye stroke that can cause sudden, permanent vision loss and has no proven treatment.

    SourcesSTAT15:56 UTCMarketWatch17:52 UTCQuartz18:50 UTCThe Independent20:20 UTCAP News20:27 UTCThe Washington Post20:50 UTCNew York Post20:51 UTCGizmodo21:46 UTCCBS News00:09 UTC
    9

    FDA requires GLP-1 drugs to warn about potential vision loss risk.

    NAION is an eye stroke that can cause sudden, permanent vision loss and has no proven treatment.
    SourcesSTAT15:56 UTCMarketWatch17:52 UTCQuartz18:50 UTCThe Independent20:20 UTCAP News20:27 UTCThe Washington Post20:50 UTCNew York Post20:51 UTCGizmodo21:46 UTCCBS News00:09 UTC